Trial Profile
Montelukast for Children With Chronic Otitis Media With Effusion (COME): A Double-blind, Placebo-controlled Study
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 30 Oct 2013
Price :
$35
*
At a glance
- Drugs Montelukast (Primary)
- Indications Otitis media
- Focus Therapeutic Use
- Acronyms COME
- 30 Oct 2013 New trial record